Vor Biopharma Inc.
VOR
$2.17
-$0.03-1.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 200.57M | 60.04M | 91.93M | 62.81M | 85.94M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.50M | 4.52M | 4.20M | 4.20M | 4.05M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.86M | 297.00K | 380.00K | 285.00K | 272.00K |
| Total Current Assets | 204.93M | 64.85M | 96.51M | 67.30M | 90.26M |
|
|
|||||
| Total Current Assets | 204.93M | 64.85M | 96.51M | 67.30M | 90.26M |
| Net Property, Plant & Equipment | 24.00K | 39.68M | 41.59M | 43.77M | 45.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 420.00K | 4.78M | 4.80M | 4.93M | 5.48M |
| Total Assets | 205.37M | 109.31M | 142.89M | 115.99M | 141.59M |
|
|
|||||
| Total Accounts Payable | 669.00K | 3.73M | 1.51M | 1.32M | 2.01M |
| Total Accrued Expenses | 58.10M | 8.69M | 12.89M | 8.87M | 7.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 4.27M | 4.22M | 4.16M | 4.11M |
| Total Finance Division Other Current Liabilities | -- | 44.00K | -- | -- | -- |
| Total Other Current Liabilities | -- | 44.00K | -- | -- | -- |
| Total Current Liabilities | 58.77M | 16.73M | 18.61M | 14.35M | 13.80M |
|
|
|||||
| Total Current Liabilities | 58.77M | 16.73M | 18.61M | 14.35M | 13.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 26.52M | 27.62M | 28.69M | 29.71M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.65B | -- | -- | -- | -- |
| Total Liabilities | 1.71B | 43.24M | 46.23M | 43.04M | 43.51M |
|
|
|||||
| Common Stock & APIC | 557.44M | 555.53M | 553.64M | 499.17M | 496.87M |
| Retained Earnings | -2.06B | -489.48M | -456.99M | -426.28M | -398.72M |
| Treasury Stock & Other | 14.00K | 23.00K | 22.00K | 68.00K | -70.00K |
| Total Common Equity | -1.51B | 66.07M | 96.66M | 72.96M | 98.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.51B | 66.07M | 96.66M | 72.96M | 98.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.51B | 66.07M | 96.66M | 72.96M | 98.08M |
|
|
|||||